BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 25747354)

  • 1. Activation of the GP130-STAT3 axis and its potential implications in nonalcoholic fatty liver disease.
    Min HK; Mirshahi F; Verdianelli A; Pacana T; Patel V; Park CG; Choi A; Lee JH; Park CB; Ren S; Sanyal AJ
    Am J Physiol Gastrointest Liver Physiol; 2015 May; 308(9):G794-803. PubMed ID: 25747354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
    Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
    J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth-suppressive activity of raloxifene on liver cancer cells by targeting IL-6/GP130 signaling.
    Wang Y; Ma H; Zhao C; Liu T; Yan D; Jou D; Li H; Zhang C; Lü J; Li C; Lin J; Li S; Lin L
    Oncotarget; 2017 May; 8(20):33683-33693. PubMed ID: 28430601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
    Di Mauro S; Ragusa M; Urbano F; Filippello A; Di Pino A; Scamporrino A; Pulvirenti A; Ferro A; Rabuazzo AM; Purrello M; Purrello F; Piro S
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice.
    Ruwanpura SM; McLeod L; Miller A; Jones J; Vlahos R; Ramm G; Longano A; Bardin PG; Bozinovski S; Anderson GP; Jenkins BJ
    Am J Physiol Lung Cell Mol Physiol; 2012 Apr; 302(7):L627-39. PubMed ID: 22268122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.
    Lam SP; Luk JM; Man K; Ng KT; Cheung CK; Rose-John S; Lo CM
    Liver Transpl; 2010 Oct; 16(10):1195-206. PubMed ID: 20879018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
    Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
    Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury.
    Klein C; Wüstefeld T; Assmus U; Roskams T; Rose-John S; Müller M; Manns MP; Ernst M; Trautwein C
    J Clin Invest; 2005 Apr; 115(4):860-9. PubMed ID: 15761498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bile acids inhibit interleukin-6 signaling via gp130 receptor-dependent and -independent pathways in rat liver.
    Graf D; Kohlmann C; Haselow K; Gehrmann T; Bode JG; Häussinger D
    Hepatology; 2006 Nov; 44(5):1206-17. PubMed ID: 17058237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis.
    Bozaykut P; Sahin A; Karademir B; Ozer NK
    Mech Ageing Dev; 2016 Jul; 157():17-29. PubMed ID: 27393639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking gp130 signaling suppresses autotaxin expression in adipocytes and improves insulin sensitivity in diet-induced obesity.
    Sun S; Wang R; Song J; Guan M; Li N; Zhang X; Zhao Z; Zhang J
    J Lipid Res; 2017 Nov; 58(11):2102-2113. PubMed ID: 28874440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsaicin inhibits the IL-6/STAT3 pathway by depleting intracellular gp130 pools through endoplasmic reticulum stress.
    Lee HK; Seo IA; Shin YK; Park JW; Suh DJ; Park HT
    Biochem Biophys Res Commun; 2009 May; 382(2):445-50. PubMed ID: 19285962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of NASH: How Metabolic Complications of Overnutrition Favour Lipotoxicity and Pro-Inflammatory Fatty Liver Disease.
    Farrell GC; Haczeyni F; Chitturi S
    Adv Exp Med Biol; 2018; 1061():19-44. PubMed ID: 29956204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemerin/CMKLR1 ameliorates nonalcoholic steatohepatitis by promoting autophagy and alleviating oxidative stress through the JAK2-STAT3 pathway.
    An X; Liu J; Li Y; Dou Z; Li N; Suo Y; Ma Y; Sun M; Tian Z; Xu L
    Peptides; 2021 Jan; 135():170422. PubMed ID: 33144092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease.
    Ceccarelli S; Panera N; Mina M; Gnani D; De Stefanis C; Crudele A; Rychlicki C; Petrini S; Bruscalupi G; Agostinelli L; Stronati L; Cucchiara S; Musso G; Furlanello C; Svegliati-Baroni G; Nobili V; Alisi A
    Oncotarget; 2015 Dec; 6(39):41434-52. PubMed ID: 26573228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 Reduces Mitochondrial Replication, and IL-6 Receptors Reduce Chronic Inflammation in NAFLD and Type 2 Diabetes.
    Skuratovskaia D; Komar A; Vulf M; Quang HV; Shunkin E; Volkova L; Gazatova N; Zatolokin P; Litvinova L
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33579000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast Cancer-Derived Exosomes Alter Macrophage Polarization
    Ham S; Lima LG; Chai EPZ; Muller A; Lobb RJ; Krumeich S; Wen SW; Wiegmans AP; Möller A
    Front Immunol; 2018; 9():871. PubMed ID: 29867925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.